Page last updated: 2024-11-01

ofloxacin and Carcinoma

ofloxacin has been researched along with Carcinoma in 2 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.

Research Excerpts

ExcerptRelevanceReference
"Prostate cancer was found in 10."1.33Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml. ( Cetinkaya, M; Inal, G; Kaygisiz, O; Koşan, M; Oztürk, B; Uğurlu, O, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baltch, AL1
Smith, RP1
Ritz, WJ1
Carpenter-Knaggs, A1
Michelsen, PB1
Carlyn, CJ1
Bopp, LH1
Hibbs, JR1
Kaygisiz, O1
Uğurlu, O1
Koşan, M1
Inal, G1
Oztürk, B1
Cetinkaya, M1

Other Studies

2 other studies available for ofloxacin and Carcinoma

ArticleYear
Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells.
    Chemotherapy, 2003, Volume: 49, Issue:1-2

    Topics: Anti-Infective Agents; Carcinoma; Chlamydia Infections; Chlamydophila pneumoniae; Hepatocytes; Human

2003
Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml.
    Prostate cancer and prostatic diseases, 2006, Volume: 9, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Biopsy; Carcinoma; Diagnosis, Differential; Humans; Male; Middle Aged;

2006